Report

reporttype1Version of Safety Report ID1receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10016430serious1Date Last Updated17/03/2014receiptdateformat102companynumbGB-ACTAVIS-2014-04599occurcountryGBduplicate1Date Received17/03/2014seriousnesshospitalization1transmissiondate02/10/2014primarysourcecountryGB

Primary Source

reportercountryGBqualification5

Patient

Onset Age21Unit of Onset AgeyearsWeight84SexFemale

Reaction

1)

reactionmeddraversionpt17.0ReactionBipolar I disorderOutcomeNot recovered/not resolved

2)

reactionmeddraversionpt17.0ReactionDepressionOutcomeNot recovered/not resolved

3)

reactionmeddraversionpt17.0ReactionMerycismOutcomeNot recovered/not resolved

4)

reactionmeddraversionpt17.0ReactionMajor depressionOutcomeNot recovered/not resolved

5)

reactionmeddraversionpt17.0ReactionAttention deficit/hyperactivity disorderOutcomeNot recovered/not resolved

6)

reactionmeddraversionpt17.0ReactionSomnolenceOutcomeNot recovered/not resolved

7)

reactionmeddraversionpt17.0ReactionSedationOutcomeNot recovered/not resolved

8)

reactionmeddraversionpt17.0ReactionAgitationOutcomeNot recovered/not resolved

Drug

1)

drugcharacterization1medicinalproductCITALOPRAM (UNKNOWN)drugbatchnumbUNCONFIRMEDdrugstructuredosagenumb20drugstructuredosageunit003drugdosagetext20 MG, UNKNOWNdrugdosageformUnkdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATIONdrugstartdateformat610drugstartdate/02/2013actiondrug1

2)

drugcharacterization1medicinalproductQUETIAPINE (UNKNOWN)drugbatchnumbUNCONFIRMEDdrugauthorizationnumb201762drugdosagetextUNKdrugdosageformUnkdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATIONdrugstartdateformat610drugstartdate/11/2013drugenddateformat610drugenddate/01/2014actiondrug1

3)

drugcharacterization1medicinalproductRISPERIDONE (UNKNOWN)drugbatchnumbUNCONFIRMEDdrugstructuredosagenumb.5drugstructuredosageunit003drugseparatedosagenumb2drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext0.5 MG, BIDdrugdosageformUnkdrugadministrationroute065drugindicationAGITATIONactiondrug1

4)

drugcharacterization1medicinalproductSTRATTERAdrugstructuredosagenumb25drugstructuredosageunit003drugdosagetext25 MG, UNKNOWNdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATIONdrugstartdateformat610drugstartdate/11/2013drugenddateformat610drugenddate/12/2013actiondrug1

openFDA Info on Medication

Application NumberNDA021411Brand NameSTRATTERAGeneric NameATOMOXETINE HYDROCHLORIDEManufacturersEli Lilly and Companyproduct_ndc0002-3227, 0002-3238, 0002-3228, 0002-3229, 0002-3239, 0002-3250, 0002-3251Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsATOMOXETINE HYDROCHLORIDERXCUI 349591, 349592, 349593, 349594, 349595, 352317, 352318, 352319, 352320, 352321, ... spl_idbef991ff-4775-4854-94c1-88081bbf9354spl_set_id309de576-c318-404a-bc15-660c2b1876fbPackage NDC 0002-3227-30, 0002-3238-30, 0002-3228-30, 0002-3229-30, 0002-3239-30, 0002-3250- ... UNII57WVB6I2W0

5)

drugcharacterization1medicinalproductSTRATTERAdrugstructuredosagenumb40drugstructuredosageunit003drugdosagetext40 MG, UNKNOWNdrugadministrationroute065drugstartdateformat610drugstartdate/10/2013drugenddateformat610drugenddate/10/2013actiondrug1

openFDA Info on Medication

6)

drugcharacterization1medicinalproductSTRATTERAdrugstructuredosagenumb60drugstructuredosageunit003drugdosagetext60 MG, UNKNOWNdrugadministrationroute065drugstartdateformat610drugstartdate/08/2013actiondrug1

openFDA Info on Medication

7)

openFDA Info on Medication

8)

openFDA Info on Medication

9)

drugcharacterization1medicinalproductSTRATTERAdrugstructuredosagenumb18drugstructuredosageunit003drugdosagetext18 MG, UNKNOWNdrugadministrationroute065drugstartdateformat610drugstartdate/11/2012actiondrug1

openFDA Info on Medication

10)

drugcharacterization1medicinalproductSTRATTERAdrugstructuredosagenumb10drugstructuredosageunit003drugdosagetext10 MG, UNKNOWNdrugadministrationroute065drugstartdateformat610drugstartdate/10/2012actiondrug1

openFDA Info on Medication

11)

drugcharacterization2medicinalproductCIRCADINdrugstructuredosagenumb8drugstructuredosageunit003drugdosagetext8 MG, UNKNOWNdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATIONdrugstartdateformat610drugstartdate/06/2013actiondrug5drugrecurreadministration3

12)

drugcharacterization2medicinalproductSERTRALINEdrugstructuredosagenumb50drugstructuredosageunit003drugdosagetext50 MG, UNKNOWNdrugadministrationroute065drugindicationAGITATIONdrugstartdateformat610drugstartdate/10/2013actiondrug5drugrecurreadministration3

openFDA Info on Medication

Application NumberANDA077670, ANDA077864, ANDA077397Brand NameSERTRALINEGeneric NameSERTRALINE, SERTRALINE HYDROCHLORIDEManufacturers Lupin Pharmaceuticals, Inc., Hikma Pharmaceuticals USA Inc., Exelan Pharmaceutic ... product_ndc 68180-351, 68180-352, 68180-353, 0143-9655, 0143-9656, 0143-9654, 76282-212, 762 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI312938, 312940, 312941spl_id 78d3579a-260f-4bb2-95f2-8ee8a60fae18, f35de481-61af-428e-abb4-a267238b3959, 5c8d ... spl_set_id 42120ff8-b353-4632-9ea9-54de9a698724, f9641190-9151-4f7e-89ff-1e7a818c30ee, 2dac ... Package NDC 68180-351-06, 68180-351-08, 68180-351-09, 68180-351-01, 68180-351-03, 68180-352- ... UNIIUTI8907Y6X

Report Duplicate

duplicatesourceACTAVISduplicatenumbGB-ACTAVIS-2014-04599

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

5)

6)

7)

8)

Drug

1)

2)

3)

4)

openFDA Info on Medication

5)

openFDA Info on Medication

6)

openFDA Info on Medication

7)

openFDA Info on Medication

8)

openFDA Info on Medication

9)

openFDA Info on Medication

10)

openFDA Info on Medication

11)

12)

openFDA Info on Medication

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us